Systemic adjuvant and perioperative chemotherapy following curative-intent liver metastasectomy in colorectal cancer—is it justified?

Description

Publication: ESMO Gastrointestinal Oncology
UBC Author(s): Daniel Renouf (Division of Medical Oncology / Faculty of Medicine), Jonathan Loree (Division of Medical Oncology / Faculty of Medicine), Sharlene Gill (Division of Medical Oncology / Faculty of Medicine)
Volume: 9
Publication Date: September 2025

Date

Mon, 09/01/2025 - 00:00

URL

https://doi.org/10.1016/j.esmogo.2025.100190